Sherry E. Courtney
Director of Clinical Research, Neonatology
Also affiliated: Rutgers, The State University of New Jersey (1998–1999); University of Toledo Medical Center (1999); Boston Children's Hospital (2007); Women & Children's Hospital of Buffalo (2006); Children's Medical Center (1984–1987); Robert Wood Johnson University Hospital (1995); Arkansas Children's Hospital (2014–2026); Northwell Health (2003–2014); Beth Israel Deaconess Medical Center (2018); Lucile Packard Children's Hospital (2021); Children's Hospital of Philadelphia (2006); Harvard University (2018); University of Louisville (2021); Johns Hopkins University (2020); Wright State University (1984–1992); Washington University in St. Louis (2006); Purdue University West Lafayette (1994); Long Island Jewish Medical Center (2003–2014); Cooper University Hospital (1995–2003); Stony Brook University Hospital (2009–2012); Johnson University (1997); Centre Hospitalier Universitaire Sainte-Justine (2021); Mercy Hospital and Medical Center (1991); University Medical Center (2001); Cooper Hospital (1998–2001); University of Illinois Chicago (1991–1992); Virtua Voorhees Hospital (2001); Johns Hopkins All Children's Hospital (2020); Mercy Children's Hospital (2002); Stony Brook Medicine (2013); University Hospital and Clinics (2001); Mercy Medical Center (2002); Dayton Children's Hospital (1987–1995); Oaklands Hospital (1998); Children's Hospital of Pittsburgh (1992); Schneider Children's Hospital (2002–2014); Rowan University (2002); Stony Brook University (2011–2012); University of Pennsylvania (2006); University of Toledo (2008); The University of Texas Health Science Center at Houston (2024)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sherry E. Courtney's research focuses on critical care for premature infants, particularly concerning respiratory health and neurodevelopmental outcomes. She investigates the epidemiology of neonatal acute respiratory distress syndrome, the effects of various medications on neurodevelopment in extremely preterm infants, and the association between racial disparities and outcomes in severe bronchopulmonary dysplasia. Courtney also explores interventions such as early versus late inguinal hernia repair in preterm infants to assess adverse event rates.
Her work includes examining the use of specific steroids like dexamethasone, prednisolone, and methylprednisolone and their impact on neurodevelopmental outcomes at two years of age in extremely preterm infants. Additionally, she studies urine biomarkers for assessing acute kidney injury in neonates with hypoxic ischemic encephalopathy who are undergoing therapeutic hypothermia. Courtney leads a research group and has a significant publication record, with an h-index of 31 and over 4,300 citations, designating her as a highly cited researcher. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including David N. Matlock, Billy Thomas, Sarah B. Mulkey, and Amit Agarwal.
Metrics
- h-index: 31
- Publications: 141
- Citations: 4,424
Selected Publications
-
A106-23 Association Between Genetic Variation in Corticotropin-releasing Hormone Receptor 1 (CRHR1) and Change in Respiratory Severity Score After Corticosteroid Treatment in Extremely Premature Infants (2026)
-
Positive end-expiratory pressure levels during resuscitation of preterm infants at birth (POLAR): study protocol for a randomised controlled trial (2026)
-
Fetal Magnetoencephalographic Power Spectral Density and Neurobehavioral Correlation in Intrauterine Growth Restriction (IUGR) (2026)
-
Can postnatal steroids or initial mode of respiratory support really impact lung function at adulthood in preterm survivors? (2025)
-
Partial waiver of consent to overcome translational science barriers in neonatal clinical research (2025)
-
Salivary cortisol is not associated with dexamethasone response in preterm infants with evolving bronchopulmonary dysplasia (2024)
-
Feasibility of synchronized high flow nasal cannula (2024)
-
Transcatheter patent ductus arteriosus closure in premature infants requiring high-frequency ventilation (2024)
-
Novel forms of ventilation in neonates: Neurally adjusted ventilatory assist and proportional assist ventilation (2024)
-
Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants (2024)
-
Neonatal high frequency ventilation: Current trends and future directions (2024)
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation (2024)
-
Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy (2024)
-
Tidal volume delivery during nasal intermittent positive pressure ventilation: infant cannula vs. nasal continuous positive airway pressure prongs (2023)
-
The effect of bethanechol on tracheobronchomalacia in preterm infants with bronchopulmonary dysplasia: a retrospective cohort study (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD) (IRB 273675) Airway Therapeutics, Inc.
- HEAL Study UAMS ACHRI Flow Through
- PENUT Trial Year 3 UAMS ACHRI Flow Through
- Developmental Impact of NICU Exposures (DINE) UAMS ACHRI Flow Through
- An Open-label, Multicenter, Randomized, Controlled Study in Spontaneously Breathing Preterm Neonates with Respiratory Distress Syndrome to Compare Two Procedures for Porcine Surfactant Administration (IRB 273485) Chiesi Farmaceutici S.p.A via Labcorp
- Trial of Late Surfactant-TOLSURF (ACHRI # 034548) UAMS ACHRI Flow Through
- Trial of Late Surfactant-TOLSURF (034348) UAMS ACHRI Flow Through
Collaboration Network
Top Collaborators
- Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study
- The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation
- Implementing a Weaning Protocol for Noninvasive Respiratory Support in Neonates Decreases Overuse and , Length of Stay
- Tidal volume delivery during nasal intermittent positive pressure ventilation: infant cannula vs. nasal continuous positive airway pressure prongs
- The effect of bethanechol on tracheobronchomalacia in preterm infants with bronchopulmonary dysplasia: a retrospective cohort study
Showing 5 of 7 shared publications
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
- Renal oximetry for early acute kidney injury detection in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia
- Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy
- Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
- Renal oximetry for early acute kidney injury detection in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia
- Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy
- Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
- Renal oximetry for early acute kidney injury detection in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia
- Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy
- Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
- Renal oximetry for early acute kidney injury detection in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia
- Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Correction to: Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
Similar Researchers
Based on overlapping research topics